ArticleMolecular therapy. Methods & clinical development2019

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis.

Linda L Kusner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.